NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump
NeutralFinancial Markets

UK ministers are considering a plan to increase the NHS's payments to pharmaceutical companies by up to 25% in an effort to resolve ongoing disputes with the industry and the Trump administration. This move comes after weeks of negotiations aimed at addressing concerns that high drug prices have led to companies cutting back on projects. The outcome of these discussions could significantly impact the availability and affordability of medications for patients in the UK.
— Curated by the World Pulse Now AI Editorial System